Aran Maree
Summary
Physician, researcher, and global life sciences leader with a track record of creating value and delivering impact. As Chief Medical Officer for the Innovative Medicine segment (formerly Janssen) at Johnson & Johnson, I bring strategic acumen, operational expertise and a commitment to innovation to deliver patient impact and organizational growth.
With over 30 years of healthcare experience, I have transitioned from providing individual patient care as a clinician to taking on global executive leadership roles, including Chief Medical Officer for both the pharmaceutical and MedTech sectors of Johnson & Johnson. I leverage extensive global, medical, and functional expertise to guide decision-making across our Clinical Development and established in-market portfolios. I am passionately committed to addressing the needs of underserved populations, including meeting the medical needs of children through targeted pediatric strategies, and facilitating access to investigational medicines via our Compassionate Use/Pre-Approval Access program.
Overview
30
30
years of professional experience
Work History
Medical Director, Head of Strategic Medical Affairs, J&J Medical Devices Australia & New Zealand
Johnson & Johnson
06.2006 - 09.2008
- Regional Management Board member and medical leader
- Regional responsibility for Medical Affairs & Patient Safety, Regulatory Affairs, Quality Assurance, Health Outcomes & Reimbursement
Associate Director, Medical Affairs & Clinical Research
Merck
06.2006 - 09.2008
- Recommenced in role after period of leave granted by Merck for work in the Middle East.
Chief Medical Officer, Pharmaceuticals
Johnson & Johnson
07.2017 - Current
- Chair of the pharmaceutical Clinical Development Committee (Phase 2/3) reviewing and guiding the company's pharmaceutical development program strategies from phase 2 through post approval across all therapeutic areas including Oncology, Immunology, Neurology, Cardiovascular & Metabolic and Infectious Diseases & Vaccines. The impact on program development includes some of the most high profile products in the company's history, including Daratumumab®, Tremfya® Carvykti®, Rybrevant®, Tecvayli®, Talvey®, Spravato® and the Janssen COVID-19 vaccine and many other important medicines under development -Oncology bi- and tri-specific antibody and CAR-T programs, Immunology mAb and small molecule and Alzheimer's programs.
- Leadership of First-in-Human Early Development Committee
- Chair of the pharmaceutical group Medical Safety Council with final safety decision-making authority for the company
- Member R&D Investment Committee approving ~$4 Billion annual spend
- >180 products and >300 development programs; Organization size >700 FTEs (direct), direct budget ~$300 Million with 120 business partners
- R&D Senior Leadership Team member.
- Proven track record of outstanding leadership across both strategic and operational areas such as translational safety, digital/AI transformation, clinical and regulatory operations, clinical development and safety governance.
- Self-motivated, with a strong sense of personal responsibility.
Chief Medical Officer, Medical Devices
Johnson & Johnson
01.2012 - 06.2017
- Global Operating Committee (Global Management Board) member
- Chair of sector Medical Safety Council with final decision-making authority for safety matters
- The Chief Medical Officer (CMO) of the Medical Devices segment of Johnson & Johnson is a key global cross functional, senior leadership role that leads clinical safety decision-making across the sector
- Led the MD&D Safety & Surveillance Group and the MD Health Informatics/Real World Evidence group
- Chair of MD Development Committee conducting final senior technical review for all major clinical development programs
Vice President, Strategic Medical Affairs, J&J Medical Devices Asia Pacific & Japan
Johnson & Johnson
09.2008 - 01.2012
- Member Asia Pacific & Japan Management Board.
- I established and led the regional Medical Affairs & Safety, Regulatory Affairs, Quality Assurance, Health Outcomes & Reimbursement
- Established a culture of continuous improvement, fostering innovation and driving sustainable growth across the organization.
Head of Health, Education & Social Affairs, Coalition Provisional Authority (MND-SE)
Department for International Development (DFID)
01.2004 - 06.2004
- Head of the regional (South-East Iraq) Health, Education and Social Affairs team for the UK Government Department for International Development (DFID) mission within the multinational Coalition Provisional Authority transitional government for Iraq.
- Worked effectively in fast-paced environments.
- Skilled at working independently and collaboratively in a team environment.
- Proven ability to learn quickly and adapt to new situations.
Associate Director, Medical Affairs & Clinical Research
Merck
01.2002 - 01.2004
- Medical Advisor and medical affairs role
- Head of the Clinical Research team, growing ANZ Phase 2 & 3 research contribution, established successful local Phase 1 collaboration and built Health Outcomes/ Market Access capabilities
-
Business Management Consultant
Boston Consulting Group (BCG)
01.2000 - 01.2002
- Advised clients on best practices for solving complex business challenges while achieving desired outcomes.
- Provided expert guidance on change management strategies, minimizing disruption during organizational transitions.
- Evaluated company performance data to identify trends and areas for improvement.
- Enhanced client satisfaction by identifying improvement opportunities and implementing strategic solutions.
Medical Doctor
Beaumont and Mater Hospitals, Dublin, Ireland and St Vincent's Hospital Sydney, Australia
06.1994 - 01.2000
- Internship, House Officer, Registrar and Fellow positions in Internal Medicine and Interventional Cardiology
Education
Bachelor of Medicine And Surgery (Honors) - Medical Doctor
RCSI (National University of Ireland)
Dublin, Ireland MRCPI - Member of The Royal College of Physicians -
The Royal College of Physicians in Ireland
Certification
- Medical Registration - Irish Medical Council (current)
- Collegiate Membership of The Royal College of Physicians of Ireland
Awards
- RCSI Council Graduation Gold Medal (1st Place) 1993
- RCSI Arthur Jacob Open Entrance Scholarship 1987 (1st Place)
- Iraq Reconstruction Service Medal, U.K. Foreign and Commonwealth Office, 2005,
Affiliations
- National Academy of Sciences, Engineering & Medicine - Forum for Drug Discovery, Development and Translation
- PhRMA Foundation Board (Board Member and Treasurer)
- J&J Patient Assistance Foundation
- The Trevor Project (Board Member and Committee Chair)
Timeline
Chief Medical Officer, Pharmaceuticals
Johnson & Johnson
07.2017 - Current
Chief Medical Officer, Medical Devices
Johnson & Johnson
01.2012 - 06.2017
Vice President, Strategic Medical Affairs, J&J Medical Devices Asia Pacific & Japan
Johnson & Johnson
09.2008 - 01.2012
Medical Director, Head of Strategic Medical Affairs, J&J Medical Devices Australia & New Zealand
Johnson & Johnson
06.2006 - 09.2008
Associate Director, Medical Affairs & Clinical Research
Merck
06.2006 - 09.2008
Head of Health, Education & Social Affairs, Coalition Provisional Authority (MND-SE)
Department for International Development (DFID)
01.2004 - 06.2004
Associate Director, Medical Affairs & Clinical Research
Merck
01.2002 - 01.2004
Business Management Consultant
Boston Consulting Group (BCG)
01.2000 - 01.2002
Medical Doctor
Beaumont and Mater Hospitals, Dublin, Ireland and St Vincent's Hospital Sydney, Australia
06.1994 - 01.2000
Bachelor of Medicine And Surgery (Honors) - Medical Doctor
RCSI (National University of Ireland)
MRCPI - Member of The Royal College of Physicians -
The Royal College of Physicians in Ireland